nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—uterine cancer	0.816	1	CbGaD
Carbimazole—CYP19A1—corpus luteum—uterine cancer	0.0252	0.563	CbGeAlD
Carbimazole—CYP19A1—semen—uterine cancer	0.0118	0.264	CbGeAlD
Carbimazole—Hepatitis cholestatic—Progesterone—uterine cancer	0.00468	0.042	CcSEcCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF3—uterine cancer	0.00382	0.135	CbGpPWpGaD
Carbimazole—Foetor hepaticus—Progesterone—uterine cancer	0.00332	0.0298	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—INHBA—uterine cancer	0.00311	0.11	CbGpPWpGaD
Carbimazole—Foetor hepaticus—Medroxyprogesterone Acetate—uterine cancer	0.00301	0.027	CcSEcCtD
Carbimazole—Liver disorder—Progesterone—uterine cancer	0.00277	0.0248	CcSEcCtD
Carbimazole—Myopathy—Progesterone—uterine cancer	0.00269	0.0241	CcSEcCtD
Carbimazole—Liver disorder—Medroxyprogesterone Acetate—uterine cancer	0.00251	0.0225	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.00217	0.0767	CbGpPWpGaD
Carbimazole—Jaundice cholestatic—Progesterone—uterine cancer	0.00215	0.0193	CcSEcCtD
Carbimazole—CYP19A1—endometrium—uterine cancer	0.00195	0.0435	CbGeAlD
Carbimazole—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.00195	0.0175	CcSEcCtD
Carbimazole—Hepatocellular injury—Progesterone—uterine cancer	0.00189	0.0169	CcSEcCtD
Carbimazole—CYP19A1—uterus—uterine cancer	0.0018	0.0401	CbGeAlD
Carbimazole—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.0153	CcSEcCtD
Carbimazole—CYP19A1—female reproductive system—uterine cancer	0.00161	0.0361	CbGeAlD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.00157	0.0554	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.00157	0.0554	CbGpPWpGaD
Carbimazole—Mouth ulceration—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.0139	CcSEcCtD
Carbimazole—CYP19A1—female gonad—uterine cancer	0.00147	0.0328	CbGeAlD
Carbimazole—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.0123	CcSEcCtD
Carbimazole—Infection—Carboplatin—uterine cancer	0.00127	0.0114	CcSEcCtD
Carbimazole—Liver function test abnormal—Progesterone—uterine cancer	0.00126	0.0113	CcSEcCtD
Carbimazole—CYP19A1—Endogenous sterols—CYP11A1—uterine cancer	0.00126	0.0443	CbGpPWpGaD
Carbimazole—Aplastic anaemia—Dactinomycin—uterine cancer	0.00125	0.0112	CcSEcCtD
Carbimazole—Mouth ulceration—Dactinomycin—uterine cancer	0.00121	0.0108	CcSEcCtD
Carbimazole—Jaundice—Progesterone—uterine cancer	0.00103	0.00923	CcSEcCtD
Carbimazole—Body temperature increased—Carboplatin—uterine cancer	0.00101	0.00909	CcSEcCtD
Carbimazole—Haemoglobin—Progesterone—uterine cancer	0.000952	0.00854	CcSEcCtD
Carbimazole—Haemorrhage—Progesterone—uterine cancer	0.000947	0.0085	CcSEcCtD
Carbimazole—Hepatitis—Progesterone—uterine cancer	0.000947	0.0085	CcSEcCtD
Carbimazole—CYP19A1—lymph node—uterine cancer	0.000945	0.0211	CbGeAlD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.00094	0.0332	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—MLH1—uterine cancer	0.000936	0.033	CbGpPWpGaD
Carbimazole—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.000932	0.00836	CcSEcCtD
Carbimazole—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.000932	0.00836	CcSEcCtD
Carbimazole—Liver function test abnormal—Dactinomycin—uterine cancer	0.000893	0.00802	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—PGR—uterine cancer	0.000887	0.0313	CbGpPWpGaD
Carbimazole—Mouth ulceration—Etoposide—uterine cancer	0.000872	0.00783	CcSEcCtD
Carbimazole—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000863	0.00774	CcSEcCtD
Carbimazole—Angiopathy—Progesterone—uterine cancer	0.000859	0.00771	CcSEcCtD
Carbimazole—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000858	0.0077	CcSEcCtD
Carbimazole—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.000858	0.0077	CcSEcCtD
Carbimazole—Alopecia—Progesterone—uterine cancer	0.000837	0.00751	CcSEcCtD
Carbimazole—Bone marrow depression—Epirubicin—uterine cancer	0.000801	0.00719	CcSEcCtD
Carbimazole—Pancytopenia—Dactinomycin—uterine cancer	0.000794	0.00713	CcSEcCtD
Carbimazole—Neutropenia—Dactinomycin—uterine cancer	0.000782	0.00702	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—ESR2—uterine cancer	0.000781	0.0275	CbGpPWpGaD
Carbimazole—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000779	0.00699	CcSEcCtD
Carbimazole—Ill-defined disorder—Progesterone—uterine cancer	0.000765	0.00687	CcSEcCtD
Carbimazole—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000758	0.00681	CcSEcCtD
Carbimazole—Angioedema—Progesterone—uterine cancer	0.000753	0.00676	CcSEcCtD
Carbimazole—Malaise—Progesterone—uterine cancer	0.000744	0.00667	CcSEcCtD
Carbimazole—Bone marrow depression—Doxorubicin—uterine cancer	0.000741	0.00665	CcSEcCtD
Carbimazole—Stomatitis—Dactinomycin—uterine cancer	0.000727	0.00652	CcSEcCtD
Carbimazole—Myalgia—Progesterone—uterine cancer	0.000702	0.0063	CcSEcCtD
Carbimazole—Arthralgia—Progesterone—uterine cancer	0.000702	0.0063	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000697	0.00626	CcSEcCtD
Carbimazole—Agranulocytosis—Dactinomycin—uterine cancer	0.000696	0.00625	CcSEcCtD
Carbimazole—Discomfort—Progesterone—uterine cancer	0.000694	0.00623	CcSEcCtD
Carbimazole—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000693	0.00622	CcSEcCtD
Carbimazole—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000683	0.00613	CcSEcCtD
Carbimazole—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000674	0.00605	CcSEcCtD
Carbimazole—Hepatitis—Dactinomycin—uterine cancer	0.00067	0.00601	CcSEcCtD
Carbimazole—Infection—Progesterone—uterine cancer	0.000669	0.006	CcSEcCtD
Carbimazole—Ageusia—Epirubicin—uterine cancer	0.000668	0.00599	CcSEcCtD
Carbimazole—Nervous system disorder—Progesterone—uterine cancer	0.00066	0.00592	CcSEcCtD
Carbimazole—Skin disorder—Progesterone—uterine cancer	0.000654	0.00587	CcSEcCtD
Carbimazole—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.00571	CcSEcCtD
Carbimazole—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.00571	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—VEGFA—uterine cancer	0.000635	0.0224	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000632	0.00567	CcSEcCtD
Carbimazole—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000629	0.00564	CcSEcCtD
Carbimazole—Ageusia—Doxorubicin—uterine cancer	0.000618	0.00554	CcSEcCtD
Carbimazole—Jaundice cholestatic—Epirubicin—uterine cancer	0.000616	0.00552	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000613	0.0055	CcSEcCtD
Carbimazole—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000606	0.00544	CcSEcCtD
Carbimazole—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000598	0.00537	CcSEcCtD
Carbimazole—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000597	0.00536	CcSEcCtD
Carbimazole—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000592	0.00532	CcSEcCtD
Carbimazole—Alopecia—Dactinomycin—uterine cancer	0.000592	0.00531	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000583	0.0206	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—SMAD3—uterine cancer	0.00058	0.0205	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000575	0.0203	CbGpPWpGaD
Carbimazole—Pancytopenia—Etoposide—uterine cancer	0.000575	0.00516	CcSEcCtD
Carbimazole—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00057	0.00511	CcSEcCtD
Carbimazole—Neutropenia—Etoposide—uterine cancer	0.000566	0.00508	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00499	CcSEcCtD
Carbimazole—Feeling abnormal—Progesterone—uterine cancer	0.000555	0.00498	CcSEcCtD
Carbimazole—Hepatocellular injury—Epirubicin—uterine cancer	0.000541	0.00485	CcSEcCtD
Carbimazole—Ill-defined disorder—Dactinomycin—uterine cancer	0.000541	0.00485	CcSEcCtD
Carbimazole—Urticaria—Progesterone—uterine cancer	0.000535	0.0048	CcSEcCtD
Carbimazole—Body temperature increased—Progesterone—uterine cancer	0.000532	0.00477	CcSEcCtD
Carbimazole—Jaundice—Etoposide—uterine cancer	0.000526	0.00472	CcSEcCtD
Carbimazole—Stomatitis—Etoposide—uterine cancer	0.000526	0.00472	CcSEcCtD
Carbimazole—Malaise—Dactinomycin—uterine cancer	0.000526	0.00472	CcSEcCtD
Carbimazole—Leukopenia—Dactinomycin—uterine cancer	0.000522	0.00468	CcSEcCtD
Carbimazole—Aplastic anaemia—Epirubicin—uterine cancer	0.000508	0.00456	CcSEcCtD
Carbimazole—Agranulocytosis—Etoposide—uterine cancer	0.000504	0.00452	CcSEcCtD
Carbimazole—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000503	0.00451	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—uterine cancer	0.0005	0.00449	CcSEcCtD
Carbimazole—Myalgia—Dactinomycin—uterine cancer	0.000496	0.00445	CcSEcCtD
Carbimazole—Hypersensitivity—Progesterone—uterine cancer	0.000496	0.00445	CcSEcCtD
Carbimazole—Discomfort—Dactinomycin—uterine cancer	0.00049	0.0044	CcSEcCtD
Carbimazole—Mouth ulceration—Epirubicin—uterine cancer	0.000489	0.00439	CcSEcCtD
Carbimazole—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000484	0.00435	CcSEcCtD
Carbimazole—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000482	0.00433	CcSEcCtD
Carbimazole—Pruritus—Progesterone—uterine cancer	0.000476	0.00427	CcSEcCtD
Carbimazole—Infection—Dactinomycin—uterine cancer	0.000473	0.00424	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000473	0.0167	CbGpPWpGaD
Carbimazole—Aplastic anaemia—Doxorubicin—uterine cancer	0.00047	0.00422	CcSEcCtD
Carbimazole—Thrombocytopenia—Dactinomycin—uterine cancer	0.000466	0.00418	CcSEcCtD
Carbimazole—Mouth ulceration—Doxorubicin—uterine cancer	0.000452	0.00406	CcSEcCtD
Carbimazole—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000449	0.00403	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000445	0.0157	CbGpPWpGaD
Carbimazole—Angiopathy—Etoposide—uterine cancer	0.00044	0.00395	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000433	0.00389	CcSEcCtD
Carbimazole—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000431	0.00387	CcSEcCtD
Carbimazole—Alopecia—Etoposide—uterine cancer	0.000428	0.00384	CcSEcCtD
Carbimazole—Rash—Progesterone—uterine cancer	0.000424	0.00381	CcSEcCtD
Carbimazole—Dermatitis—Progesterone—uterine cancer	0.000424	0.0038	CcSEcCtD
Carbimazole—Headache—Progesterone—uterine cancer	0.000422	0.00378	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000414	0.0146	CbGpPWpGaD
Carbimazole—Nausea—Progesterone—uterine cancer	0.0004	0.00359	CcSEcCtD
Carbimazole—Feeling abnormal—Dactinomycin—uterine cancer	0.000392	0.00352	CcSEcCtD
Carbimazole—Ill-defined disorder—Etoposide—uterine cancer	0.000391	0.00351	CcSEcCtD
Carbimazole—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000385	0.00345	CcSEcCtD
Carbimazole—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000384	0.00345	CcSEcCtD
Carbimazole—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000382	0.00343	CcSEcCtD
Carbimazole—Malaise—Etoposide—uterine cancer	0.00038	0.00341	CcSEcCtD
Carbimazole—Leukopenia—Etoposide—uterine cancer	0.000378	0.00339	CcSEcCtD
Carbimazole—Body temperature increased—Dactinomycin—uterine cancer	0.000376	0.00337	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.00037	0.013	CbGpPWpGaD
Carbimazole—Liver function test abnormal—Epirubicin—uterine cancer	0.000362	0.00325	CcSEcCtD
Carbimazole—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000362	0.00325	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000357	0.0032	CcSEcCtD
Carbimazole—Discomfort—Etoposide—uterine cancer	0.000355	0.00318	CcSEcCtD
Carbimazole—Hypersensitivity—Dactinomycin—uterine cancer	0.00035	0.00315	CcSEcCtD
Carbimazole—Infection—Etoposide—uterine cancer	0.000342	0.00307	CcSEcCtD
Carbimazole—Thrombocytopenia—Etoposide—uterine cancer	0.000337	0.00303	CcSEcCtD
Carbimazole—Eosinophilia—Epirubicin—uterine cancer	0.000336	0.00302	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—uterine cancer	0.000335	0.00301	CcSEcCtD
Carbimazole—Skin disorder—Etoposide—uterine cancer	0.000334	0.003	CcSEcCtD
Carbimazole—TPO—Metabolism—NDUFB11—uterine cancer	0.000326	0.0115	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SRD5A2—uterine cancer	0.000326	0.0115	CbGpPWpGaD
Carbimazole—Pancytopenia—Epirubicin—uterine cancer	0.000322	0.00289	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CDKN1B—uterine cancer	0.000322	0.0114	CbGpPWpGaD
Carbimazole—Neutropenia—Epirubicin—uterine cancer	0.000317	0.00285	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—uterine cancer	0.000311	0.00279	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000304	0.0107	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	0.0003	0.0106	CbGpPWpGaD
Carbimazole—Rash—Dactinomycin—uterine cancer	0.0003	0.00269	CcSEcCtD
Carbimazole—Pancytopenia—Doxorubicin—uterine cancer	0.000298	0.00268	CcSEcCtD
Carbimazole—Jaundice—Epirubicin—uterine cancer	0.000295	0.00265	CcSEcCtD
Carbimazole—Stomatitis—Epirubicin—uterine cancer	0.000295	0.00265	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—uterine cancer	0.000294	0.00264	CcSEcCtD
Carbimazole—Feeling abnormal—Etoposide—uterine cancer	0.000284	0.00255	CcSEcCtD
Carbimazole—Nausea—Dactinomycin—uterine cancer	0.000283	0.00254	CcSEcCtD
Carbimazole—Agranulocytosis—Epirubicin—uterine cancer	0.000282	0.00253	CcSEcCtD
Carbimazole—Urticaria—Etoposide—uterine cancer	0.000273	0.00245	CcSEcCtD
Carbimazole—Haemoglobin—Epirubicin—uterine cancer	0.000273	0.00245	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—uterine cancer	0.000273	0.00245	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—uterine cancer	0.000273	0.00245	CcSEcCtD
Carbimazole—Body temperature increased—Etoposide—uterine cancer	0.000272	0.00244	CcSEcCtD
Carbimazole—Haemorrhage—Epirubicin—uterine cancer	0.000272	0.00244	CcSEcCtD
Carbimazole—Hepatitis—Epirubicin—uterine cancer	0.000272	0.00244	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—GPX3—uterine cancer	0.000267	0.00941	CbGpPWpGaD
Carbimazole—Agranulocytosis—Doxorubicin—uterine cancer	0.000261	0.00234	CcSEcCtD
Carbimazole—Hypersensitivity—Etoposide—uterine cancer	0.000254	0.00228	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—uterine cancer	0.000253	0.00227	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—uterine cancer	0.000251	0.00226	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—uterine cancer	0.000251	0.00226	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP11A1—uterine cancer	0.000251	0.00885	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000248	0.00873	CbGpPWpGaD
Carbimazole—Angiopathy—Epirubicin—uterine cancer	0.000246	0.00221	CcSEcCtD
Carbimazole—Pruritus—Etoposide—uterine cancer	0.000244	0.00219	CcSEcCtD
Carbimazole—Alopecia—Epirubicin—uterine cancer	0.00024	0.00215	CcSEcCtD
Carbimazole—TPO—Metabolism—STAR—uterine cancer	0.000235	0.0083	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKR1B1—uterine cancer	0.000235	0.0083	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000234	0.00825	CbGpPWpGaD
Carbimazole—Angiopathy—Doxorubicin—uterine cancer	0.000228	0.00205	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000223	0.00786	CbGpPWpGaD
Carbimazole—Alopecia—Doxorubicin—uterine cancer	0.000222	0.00199	CcSEcCtD
Carbimazole—Ill-defined disorder—Epirubicin—uterine cancer	0.000219	0.00197	CcSEcCtD
Carbimazole—Rash—Etoposide—uterine cancer	0.000217	0.00195	CcSEcCtD
Carbimazole—Dermatitis—Etoposide—uterine cancer	0.000217	0.00195	CcSEcCtD
Carbimazole—Headache—Etoposide—uterine cancer	0.000216	0.00194	CcSEcCtD
Carbimazole—Malaise—Epirubicin—uterine cancer	0.000213	0.00191	CcSEcCtD
Carbimazole—Leukopenia—Epirubicin—uterine cancer	0.000212	0.0019	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—STK11—uterine cancer	0.000205	0.00723	CbGpPWpGaD
Carbimazole—Nausea—Etoposide—uterine cancer	0.000204	0.00184	CcSEcCtD
Carbimazole—Ill-defined disorder—Doxorubicin—uterine cancer	0.000203	0.00182	CcSEcCtD
Carbimazole—Arthralgia—Epirubicin—uterine cancer	0.000201	0.00181	CcSEcCtD
Carbimazole—Myalgia—Epirubicin—uterine cancer	0.000201	0.00181	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.0002	0.00179	CcSEcCtD
Carbimazole—Discomfort—Epirubicin—uterine cancer	0.000199	0.00179	CcSEcCtD
Carbimazole—Malaise—Doxorubicin—uterine cancer	0.000197	0.00177	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—uterine cancer	0.000196	0.00176	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—uterine cancer	0.000196	0.0069	CbGpPWpGaD
Carbimazole—Infection—Epirubicin—uterine cancer	0.000192	0.00172	CcSEcCtD
Carbimazole—Nervous system disorder—Epirubicin—uterine cancer	0.000189	0.0017	CcSEcCtD
Carbimazole—Thrombocytopenia—Epirubicin—uterine cancer	0.000189	0.0017	CcSEcCtD
Carbimazole—Skin disorder—Epirubicin—uterine cancer	0.000187	0.00168	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—uterine cancer	0.000186	0.00167	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—uterine cancer	0.000186	0.00167	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000185	0.00166	CcSEcCtD
Carbimazole—TPO—Metabolism—POLD1—uterine cancer	0.000185	0.00652	CbGpPWpGaD
Carbimazole—Discomfort—Doxorubicin—uterine cancer	0.000184	0.00165	CcSEcCtD
Carbimazole—Infection—Doxorubicin—uterine cancer	0.000177	0.00159	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000176	0.00158	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—uterine cancer	0.000175	0.00157	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—uterine cancer	0.000175	0.00157	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—uterine cancer	0.000173	0.00156	CcSEcCtD
Carbimazole—TPO—Metabolism—AKR1C1—uterine cancer	0.000173	0.00609	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000163	0.00146	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000161	0.00568	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000161	0.00568	CbGpPWpGaD
Carbimazole—Feeling abnormal—Epirubicin—uterine cancer	0.000159	0.00143	CcSEcCtD
Carbimazole—TPO—Metabolism—RRM2—uterine cancer	0.000154	0.00543	CbGpPWpGaD
Carbimazole—Urticaria—Epirubicin—uterine cancer	0.000153	0.00138	CcSEcCtD
Carbimazole—Body temperature increased—Epirubicin—uterine cancer	0.000153	0.00137	CcSEcCtD
Carbimazole—TPO—Metabolism—DCN—uterine cancer	0.000149	0.00527	CbGpPWpGaD
Carbimazole—Feeling abnormal—Doxorubicin—uterine cancer	0.000147	0.00132	CcSEcCtD
Carbimazole—Hypersensitivity—Epirubicin—uterine cancer	0.000142	0.00128	CcSEcCtD
Carbimazole—Urticaria—Doxorubicin—uterine cancer	0.000142	0.00127	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—uterine cancer	0.000141	0.00127	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP11A1—uterine cancer	0.000141	0.00497	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	0.000137	0.00483	CbGpPWpGaD
Carbimazole—Pruritus—Epirubicin—uterine cancer	0.000137	0.00123	CcSEcCtD
Carbimazole—TPO—Metabolism—AKR1C3—uterine cancer	0.000133	0.00469	CbGpPWpGaD
Carbimazole—Hypersensitivity—Doxorubicin—uterine cancer	0.000132	0.00118	CcSEcCtD
Carbimazole—Pruritus—Doxorubicin—uterine cancer	0.000126	0.00113	CcSEcCtD
Carbimazole—Rash—Epirubicin—uterine cancer	0.000122	0.00109	CcSEcCtD
Carbimazole—Dermatitis—Epirubicin—uterine cancer	0.000122	0.00109	CcSEcCtD
Carbimazole—Headache—Epirubicin—uterine cancer	0.000121	0.00109	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	0.000119	0.0042	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000118	0.00417	CbGpPWpGaD
Carbimazole—Nausea—Epirubicin—uterine cancer	0.000115	0.00103	CcSEcCtD
Carbimazole—Rash—Doxorubicin—uterine cancer	0.000113	0.00101	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—uterine cancer	0.000112	0.00101	CcSEcCtD
Carbimazole—Headache—Doxorubicin—uterine cancer	0.000112	0.001	CcSEcCtD
Carbimazole—Nausea—Doxorubicin—uterine cancer	0.000106	0.000952	CcSEcCtD
Carbimazole—TPO—Metabolism—STK11—uterine cancer	0.000104	0.00366	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP19A1—uterine cancer	0.000104	0.00366	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SRD5A2—uterine cancer	9.92e-05	0.0035	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NDUFB11—uterine cancer	9.92e-05	0.0035	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.64e-05	0.0034	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.1e-05	0.00321	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	8.79e-05	0.0031	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	8.57e-05	0.00302	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	8.17e-05	0.00288	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTHFR—uterine cancer	7.79e-05	0.00275	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	7.74e-05	0.00273	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—STAR—uterine cancer	7.17e-05	0.00253	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKR1B1—uterine cancer	7.17e-05	0.00253	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	6.58e-05	0.00232	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	5.85e-05	0.00206	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—POLD1—uterine cancer	5.63e-05	0.00199	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKR1C1—uterine cancer	5.27e-05	0.00186	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	4.94e-05	0.00174	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—RRM2—uterine cancer	4.69e-05	0.00166	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—DCN—uterine cancer	4.56e-05	0.00161	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—uterine cancer	4.33e-05	0.00153	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP11A1—uterine cancer	4.29e-05	0.00151	CbGpPWpGaD
Carbimazole—TPO—Metabolism—EP300—uterine cancer	4.13e-05	0.00146	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKR1C3—uterine cancer	4.05e-05	0.00143	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—STK11—uterine cancer	3.16e-05	0.00111	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—uterine cancer	3.06e-05	0.00108	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.96e-05	0.00105	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.83e-05	0.000997	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—uterine cancer	2.5e-05	0.000881	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTHFR—uterine cancer	2.37e-05	0.000837	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.09e-05	0.000738	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—uterine cancer	1.32e-05	0.000466	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—EP300—uterine cancer	1.26e-05	0.000444	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—uterine cancer	9.31e-06	0.000329	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—uterine cancer	7.61e-06	0.000268	CbGpPWpGaD
